Bromide

Bromide

SCHEMBL198106

CC[P+](CC)(CC)CCOC.[Br-]

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30716694 0.97 PIK3CD (0.33) PIK3CD
Hydrochloric Acid SCHEMBL1408651 0.94 PIK3CD (0.32) PIK3CD
SCHEMBL198032 0.87
Thiocyanic Acid SCHEMBL4933402 0.83
SCHEMBL30799108 0.81 CA2 (0.32)
Hydrochloric Acid SCHEMBL10930879 0.78 PIK3CD (0.31) PIK3CD
Bromide SCHEMBL4302304 0.76 DNM1 (0.56)
Trifluoromethanesulfonic Acid SCHEMBL4940307 0.75 ACHE (0.34)
SCHEMBL29388075 0.72 DNM1 (0.55)
SCHEMBL30869322 0.71 PIK3CD (0.32) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939521-B2 Reuse of hypersaline brine with ionic liquids SAUDI ARABIAN OIL COMPANY (SA) 2024-03-26 US disclosed
US-20240059958-A1 REUSE OF HYPERSALINE BRINE WITH IONIC LIQUIDS SAUDI ARABIAN OIL COMPANY (SA) 2024-02-22 US disclosed
WO-2024039814-A1 REUSE OF HYPERSALINE BRINE WITH IONIC LIQUIDS SAUDI ARABIAN OIL COMPANY (SA) 2024-02-22 WO disclosed
US-20220127293-A1 LIQUID METAL COMPLEX HAVING OXYGEN-ABSORBING ABILITY SHARP KABUSHIKI KAISHA (JP) 2022-04-28 US disclosed
EP-3409343-B1 LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME SHARP KK (JP) 2021-04-28 EP disclosed
US-10814269-B2 Liquid having oxygen absorbing ability, method for producing same, and complex solution containing same SHARP KABUSHIKI KAISHA (JP) 2020-10-27 US disclosed
US-20190291046-A1 OXYGEN SEPARATION MEMBRANE SHARP KABUSHIKI KAISHA (JP) 2019-09-26 US disclosed
EP-3485965-A1 OXYGEN SEPARATION MEMBRANE Sharp Kabushiki Kaisha (JP) 2019-05-22 EP disclosed
US-20190001260-A1 LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME NATIONAL UNIVERSITY CORP. KOBE UNIVERSITY (JP) 2019-01-03 US disclosed
EP-3409343-A1 LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME Sharp Kabushiki Kaisha (JP) 2018-12-05 EP disclosed
US-8088995-B2 Electrolyte composition for photoelectric conversion device and photoelectric conversion device using the same TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2012-01-03 US disclosed
US-20110083744-A9 ELECTROLYTE COMPOSITION FOR PHOTOELECTRIC CONVERSION DEVICE AND PHOTOELECTRIC CONVERSION DEVICE USING THE SAME TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2011-04-14 US disclosed
US-20090065058-A1 ELECTROLYTE COMPOSITION FOR PHOTOELECTRIC CONVERSION DEVICE AND PHOTOELECTRIC CONVERSION DEVICE USING THE SAME TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2009-03-12 US disclosed
US-20090053597-A1 ELECTROLYTE COMPOSITION USED IN CHARGE STORAGE DEVICE AND STORAGE DEVICE USING THE SAME NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2009-02-26 US disclosed
US-20080221353-A1 Novel phosphonium salt ionic liquid and reaction solvent including the same NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10814269-B2 Liquid having oxygen absorbing ability, method for producing same, and complex solution containing same MB, OTC, OAT PIK3CD 3718/4885
US-20190291046-A1 OXYGEN SEPARATION MEMBRANE NCLN, OXA1L, MB PIK3CD 962/4885
US-20080221353-A1 Novel phosphonium salt ionic liquid and reaction solvent including the same PIK3R5, PIP4K2B, PIP5K1B PIK3CD 10/4885
US-20220127293-A1 LIQUID METAL COMPLEX HAVING OXYGEN-ABSORBING ABILITY OTC, CA9, SLC39A14 PIK3CD 4772/4885
US-20190001260-A1 LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME MB, OTC, OAT PIK3CD 3718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.